Alendronate Sodium & Cholecalciferol Articles
Bisphosphonates under scrutiny in Europe over link to stress fractures
28 September 2010
Merck & Co's 2nd-qtr 2007 EPS jumps 12%
30 July 2007
Merck & Co's 1st-qtr income climbs 12%
30 April 2007
Merck & Co sees 1st-qtr net income of $1.52B
1 May 2006
Merck & Co beats forecasts; profit up 2%
6 February 2006
Vioxx loss drags on Merck & Co results
22 April 2005
FDA clears Merck & Co's enhanced Fosamax
18 April 2005
Showing 1-7 of 7 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
